• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

MedImmune (biologics division of AstraZeneca)

MedImmune is the global biologics research and development arm of AstraZeneca. MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic areas, including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. The MedImmune headquarters is located in Gaithersburg, Md., one of AstraZeneca’s three global R&D centres. *

 

	Start	1988-01-01 established_pre
	Group	AstraZeneca (Group)
	Predecessor	MedImmune Inc. (Nasdaq: MEDI)
	Industry	pharmaceutical
	Region	Gaithersburg, MD
	Country	United States (USA)
	Street	One MedImmune Way
	City	20878 Gaithersburg, MD
		Address record changed: 2020-12-02
Basic data	Employees	F: 1,001 to 5,000 (2005-05-14)
		* Document for �About Section�:
		Record changed: 2020-06-14

Advertisement

More documents for AstraZeneca (Group)

• [1] Immunocore Holdings plc. (2/16/21). "Press Release: Immunocore Announces Key Appointments to Management and Board". Oxfordshire & Conshohocken, PA....
• [2] AstraZeneca plc. (12/30/20). "Press Release: AstraZeneca’s COVID-19 Vaccine Authorised for Emergency Supply in the UK"....
• [3] AstraZeneca plc. (12/12/20). "Press Release: AstraZeneca to Acquire Alexion, Accelerating the Company’s Strategic and Financial Development [Not for any jurisdicition where violation of relevant laws]"....
• [4] Exscientia Ltd.. (11/10/20). "Press Release: Exscientia Recruits Industry Innovator Garry Pairaudeau as Chief Technology Officer"....
• [5] Fusion Antibodies Ltd.. (11/6/20). "Press Release: Fusion Antibodies Announce New Senior Hire to Support Innovation"....
• [6] Nvidia Corporation. (10/5/20). "Press Release: Nvidia Building UK’s Most Powerful Supercomputer, Dedicated to AI Research in Healthcare". Santa Clara, CA....
• [7] Oxford BioMedica plc. (9/1/20). "Press Release: Oxford Biomedica Signs Supply Agreement with AstraZeneca to Expand Manufacturing Support of COVID-19 Vaccine Candidate, AZD1222". Oxford....
• [8] Cellink AB. (8/27/20). "Press Release: Cytena and AstraZeneca Collaborate to Develop Plate Based Microbioreactors for Cell Line Development Workflows"....
• [9] Redx Pharma plc. (8/4/20). "Press Release: Redx Signs Out Licensing Agreement with AstraZeneca". Alderley Park....
• [10] ImaginAb, Inc.. (3/30/20). "Press Release: ImaginAb Announces Licensing Deal with AstraZeneca for CD8 ImmunoPET Technology". Los Angeles, CA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.